Edition:
United Kingdom

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

97.64USD
23 May 2019
Change (% chg)

$0.02 (+0.02%)
Prev Close
$97.62
Open
$97.36
Day's High
$97.65
Day's Low
$96.60
Volume
260,116
Avg. Vol
303,354
52-wk High
$116.43
52-wk Low
$78.97

Prevoznik, Michael 

Mr. Michael E. Prevoznik is Senior Vice President, General Counsel of the Company. Mr. Prevoznik joined the Company as Vice President and General Counsel in August 1999. In 2003, he assumed responsibility for governmental affairs. From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department. In addition, from April 2011 to January 2017, he had management responsibility for the Company's diagnostic information services activities outside the U.S., and from April 2011 to January 2013, he had management responsibility for the Company's clinical trials business. Prior to joining the Company, Mr. Prevoznik served in positions of increasing responsibility within the compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with responsibility for coordinating all SmithKline Beecham compliance activities worldwide.

Basic Compensation

Total Annual Compensation, USD 694,353
Restricted Stock Award, USD 858,026
Long-Term Incentive Plans, USD --
All Other, USD 538,009
Fiscal Year Total, USD 2,090,390

Options Compensation

  Quantity Market Value
Exercisable 262,378 6,381,430.00
Unexercisable 125,552 1,325,690.00
Exercised 126,667 2,793,390.00
Name Fiscal Year Total

Stephen Rusckowski

10,348,000

Mark Guinan

3,460,400

James Davis

3,270,240

Gabrielle Wolfson

--

Michael Prevoznik

2,090,390

Jon Cohen

2,491,990
As Of  31 Dec 2017